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maging plays a central role in the diagnosis andmanagement of coronary artery disease. Imaging is used
or the detection of underlying coronary artery stenoses in patients with stable or chronic chest pain, for
he assessment of myocardial scar and viability, for assessing prognosis, or for predicting complications.
chocardiography, nuclear imaging, cardiac magnetic resonance, and—more recently—computed to-
ography are powerful tools to provide answers to these questions. New technology, new contrast
gents, and newly developed imaging protocols widen the applicability and increase accuracy of these
maging modalities, and new clinical studies provide information on their diagnostic potential and their
herapeutic as well as prognostic value. The relative strengths and weaknesses of the different imaging
odalities influence the selectionof themost appropriate imaging approach indifferent clinical scenarios.
his article outlines some of the most important developments of the past 12 months in the field of
chocardiography, nuclear imaging, cardiac magnetic resonance, and computed tomography as they
ertain to coronary artery disease. (J Am Coll Cardiol Img 2010;3:1065–77) © 2010 by the American
ollege of Cardiology Foundationp
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n all areas of cardiac imaging, new novel
echnologies or imaging approaches might
ave substantial clinical impact when imaging
onditions are difficult. Echocardiography for
xample might be hampered by low-quality
mages that would make accurate evaluation of
entricular function difficult, which in turn
ight lead to increased downstream use of
ther diagnostic modalities. The impact of
ontrast echocardiography on management in
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1066tandard 2-dimensional echocardiography (2).
dding global longitudinal strain (hazard ratio
HR]: 1.45) to clinical factors was more powerful
n predicting cardiac events than wall motion score
ndex (HR:  1.28) or ejection fraction (HR: 
.23). A global longitudinal strain cutoff of12%
as equivalent to an ejection fraction of 35% in
redicting prognosis.
Novel developments in 3-dimensional echocardi-
graphy include the application of speckle tracking to
ssess regional LV function. Seo et al. (3) validated
V strain measurements by 3-dimensional speckle
racking against data obtained by sonomicrometry in a
sheep model of acute ischemia and pharma-
cologic stress. Good correlations were ob-
served between noninvasive and invasive
strain measurements (r range 0.84 to 0.90).
New data have become available con-
cerning imaging of “ischemic memory”
through nuclear medicine. After a transient
ischemic event, persistent metabolic distur-
bances in fatty acid metabolism can occur for
up to 30 h—termed “ischemic memory” (4).
Radioiodine-labeled branched-chain fatty
acid -methyl--[123I]-iodophenyl-
pentadecanoic acid (BMIPP) allows as-
sessment of fatty acid metabolism with
single-photon emission computed tomog-
raphy (SPECT). In a recent multicenter
trial, 448 emergency department patients
with suspected acute coronary syndrome
(ACS) were enrolled at 50 centers (5).
Patients were imaged with BMIPP within
30 h of symptom cessation. Compared
with initial clinical diagnosis alone, the
combination of BMIPP with initial clinical
diagnosis increased sensitivity for identify-
ing patients with ACS from 43% to 81%
(p 0.001), negative predictive value from
62% to 83% (p  0.001), and positive
predictive value from 41% to 58% (p 
.001), while maintaining specificity (61% to 62%,
 NS) (Fig. 1).
Another new tracer to study myocardial perfu-
ion with positron emission tomography (PET) is
n F-18 labeled pyridazone derivate, F-18 BMS.
ecause of the short physical half-life of
ubidium-82 (75 s), stress myocardial perfusion
ubidium PET studies are commonly performed
ith a pharmacologic vasodilator rather than exer-
ise. The longer half-life of F-18 BMS (110 min)
ould allow its application as a perfusion agent
ome
cid
ass
se
r
iac
y
ssionuring treadmill exercise as well as widen the wlinical application of cardiac PET by allowing a
ingle-dose unit distribution on a daily basis. In a
orcine model of transient ischemia, myocardial
ptake of F-18 BMS was compared with N-13
mmonia and radioactive microspheres (6). There
as a relatively good correlation between the extent
f myocardial perfusion defects measured by F-18
MS and microspheres (r  0.63, slope  1.1) (7).
ptake ratios of myocardium-to-blood, myocardium-
o-lung, and blood-to-liver were up to 3-fold higher
or F-18 BMS than N-13 ammonia.
New contrast agents have also been evaluated for
agnetic resonance (MR) imaging. A new collagen
inding gadolinium-based contrast agent was tested
n a porcine model of myocardial ischemia and
hown to accurately assess perfusion defects (8). An
lbumin-bound gadolinium-based intravascular
ontrast agent was approved by the U.S. Food and
rug Administration for human use in peripheral
R angiography after pilot studies for whole-heart
R coronary angiography at 3.0-T were promising
9). Stronger magnetic fields might improve MR
maging. The first feasibility studies of cardiac
maging in humans on whole body 7.0-T MR
canners have been performed with fairly basic pulse
equences and promising initial results (10).
In X-ray computed tomography (CT) imaging,
ardware specifications continue to improve. First
linical results of 320-slice scanners—albeit in small
atient groups—have become available and indicate
igh diagnostic accuracy (11,12). In 64 patients, a
ecent study performed by 320-slice CT demon-
trated a per-patient sensitivity of 100% and spec-
ficity of 88% for the identification of individuals
ith at least 1 stenosis 50%. Especially for pa-
ients with low heart rates, limiting data acquisition
o 1 single cardiac cycle allowed achievement of low
adiation exposure (with a mean estimated effective
ose of 3.9  1.3 mSv for heart rates 60 beats/
in) (12). With a recently introduced second-
eneration dual source CT system, providing both
ncreased detector coverage and rotation speed as
ompared with first-generation dual source CT, a
ew data acquisition mode has become possible for
oronary CT angiography. Prospectively, electro-
ardiogram (ECG)-triggered spiral acquisition with
igh pitch values allows extremely low radiation
oses. It has so far only been evaluated in small
eries of selected patients (13–16). In a series of 50
atients with suspected coronary artery disease
CAD), a heart rate below 60 beats/min and a bodyB B R E V I A T I O N S
N D A C R O N YM S
CS acute coronary syndr
MIPP-methyl--[123I]-
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ABG coronary artery byp
rafting
AD coronary artery disea
FR coronary flow reserve
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T computed tomography
CG electrocardiogram
R hazard ratio
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nhancement
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ACEmajor adverse card
vents
Rmagnetic resonance
CI percutaneous coronar
ntervention
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1067Sv was consistently achieved (mean dose: 0.87 
.07 mSv) (Fig. 2) (17).
iagnosis of CAD
ssessment of “diastolic stunning” might be a new
pproach to detect ischemia in echocardiography.
shii et al. (18) evaluated whether post-ischemic
elayed LV relaxation could be detected with strain
maging from 2-dimensional speckle-tracking
chocardiography. Changes in regional LV strain
uring the first third of diastole were determined in
62 patients with effort angina. Ten minutes after
xercise, regional delayed relaxation was still ob-
erved in 85% of ischemic territories (Fig. 3). A
train imaging diastolic index ratio had a sensitivity
f 97% and a specificity of 93% to detect significant
oronary stenosis (18).
A recent study evaluated the detection of CAD
ith perfusion stress dipyridamole echocardiogra-
hy with a novel ultrasound imaging agent (Ima-
ify, Acusphere, Cambridge, Massachusetts) in
omparison with radionuclide perfusion imaging.
eal-time Assessment of Myocardial Perfusion 1
nd 2 were international, phase 3 trials in 662
atients. Accuracy for perfusion stress echo (66% to
1%) was noninferior to SPECT (67% to 70%)
Fig. 4) (19).
The strength and basis of nuclear imaging is the
ssessment of heterogeneity in myocardial perfusion
t rest and during hyperemic flow. As opposed to
isual or semi-quantitative interpretation of relative
egional radiotracer uptake where the myocardial
egion with highest uptake is considered normal,
ET myocardial perfusion imaging allows for the
ssessment of absolute myocardial blood flow in
l/min/g. In a recent publication (20), it was
ypothesized that absolute measurement of myo-
Figure 2. Very Low-Dose Coronary CT Angiography With Prospe
With a Dual Source CT System
A multiplanar reconstruction of the right coronary artery, left main,
length product of this computed tomography (CT) angiography inv
dose of 0.7 mSv.ardial blood flow (ml/min/g) by 13N-ammonia
ET is superior to relative measurement of myo-
ardial tracer retention (nCi/ml) for identification
f CAD (70% diameter stenosis). In 48 subjects,
he authors demonstrated that “single” adenosine
asodilator stress-stimulated PET measurement of
bsolute myocardial blood flow was all that was
eeded to attain sensitivity, specificity, and accura-
ies of 81%, 85%, and 84%, respectively, for detect-
ng CAD. When myocardial blood flow reserve of
ess than 2-fold increase in adenosine-induced
yocardial blood flow from rest was used (2 sets of
In Clin Dx
In Clin Dx + BMIPP
%
0
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Figure 1. Incremental Value of BMIPP SPECT to Initial Clinical In
Emergency Department for Early Diagnosis of Acute Coronary S
Performance characteristics for the initial clinical diagnosis (In Clin D
combination of the initial clinical diagnosis and -methyl--[123I]-io
canoic acid (BMIPP) single-photon emission computed tomography
shown. The combination of BMIPP SPECT with initial clinical inform
improved sensitivity for identifying patients with acute coronary syn
with the sensitivity of the In Clin Dx alone, while maintaining speci
tive predictive value; PPV  positive predictive value. Reprinted, wi
Kontos et al. (5).
e Electrocardiogram-Triggered High-Pitch Spiral Acquisition
left anterior descending coronary artery is shown. The dose
ation was 47 cm*mGy, corresponding to an estimated effectivePPV
41
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p< 0.001
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yndromes
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(SPECT) imaging are
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1068mages), the sensitivity, specificity, and accuracies
ere 62%, 85%, and 79%, respectively. When
elative radiotracer uptake of 70% (normalized to
eak normal reference region) was used, the sensi-
ivity, specificity, and accuracies were 48%, 82%,
nd 72%, respectively. Hence, absolute myocardial
lood flow on “single” adenosine PET images
howed improved sensitivity without decreasing
pecificity, which might simplify clinical PET myo-
ardial perfusion imaging for evaluation of patients
ith known or suspected CAD (20,21).
New nuclear cameras might also translate into
etter diagnosis of CAD. In a prospective, multi-
enter clinical trial of 238 patients, the authors used
uantitative analysis to compare the ability of high-
peed SPECT (which acquired images in one-
eventh of the time) with that of conventional
PECT in detecting myocardial perfusion abnor-
alities (22,23). High-speed stress and rest total
erfusion deficit correlated linearly with conven-
Figure 3. 2D Speckle Tracking Images and Transverse Strain Cu
The 2-dimensional (2D) speckle tracking images in the apical long-a
(orange curve) and mid-inferolateral (purple curve) segments (bott
stenosis in segment 7 of the left anterior descending coronary arte
exercise. Top: The color bar of strain is set as yellow according to i
decrease of peak systolic strain developed in the mid-anteroseptal
level or yellow mapping area (yellow arrow) appeared in the mid-a
ischemic delayed reaction. After 10 min, the yellow mapping area h
segments at one-third duration. Bottom: At baseline, the strain ima
The index decreased to 4% 5 min after exercise and improved but
segment. No apparent changes of SI-diastolic index were observed
DD  one-third diastole duration; 5 min  5 min after treadmill ex
anteroseptal; AVC  aortic valve closure; IL  mid-inferolateral. Repional SPECT (r  0.95 and r  0.97, respectively, p 0.0001). Post-stress ejection fraction and end-
iastolic volume by the 2 methods were linearly
orrelated (r  0.89 and r  0.97, respectively).
hus, high-speed SPECT measures of myocardial
erfusion and function are comparable to those
ith conventional SPECT, with imaging com-
leted in 2 to 4 min (23,24).
Data on the excellent accuracy of cardiac mag-
etic resonance (CMR) perfusion imaging for iden-
ification of ischemia continue to accumulate. In a
tudy of 103 patients who underwent invasive
easurement of fractional flow reserve, the sensi-
ivity and specificity of CMR first-pass contrast-
nhanced perfusion was 91% and 94%, respectively
25). In patients with prior percutaneous coronary
ntervention (PCI) or coronary artery bypass graft-
ng (CABG) who had been typically excluded from
rior studies of this kind, the combined use of
erfusion imaging and late gadolinium enhance-
ent (LGE) performed well to identify post-PCI
view (top) and transverse strain curves in mid-anteroseptal
), obtained from a 68-year-old male patient with 70% coronary
baseline, immediately after and 5 and 10 min after the treadmill
asing strain value. Immediately after exercise, a signiﬁcant
ent (white arrow). Five minutes after exercise, the high strain
oseptal segment at one-third diastole duration, because of post-
aded out but is still present in the mid-anteroseptal and apical
(SI)-diastolic index was 76% in the mid-anteroseptal segment.
ained depressed (23%) 10 min after exercise in the anteroseptal
ng the follow-up period in the mid-inferolateral segment. 1/3
e; 10 min  10 min after treadmill exercise; AS  mid-
ed, with permission, from Ishii et al. (18).rves
xis
om
ry at
ncre
segm
nter
as f
ging
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ercisatients with coronary stenoses (sensitivity 91%
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1069nd specificity 90%), although it was less accurate
ost-CABG (sensitivity 79%, specificity 77%)
Fig. 5) (26).
Noninvasive coronary angiography continues to
ncrease in robustness. In a single-center study of
atients with a mean body mass index of 24 kg/m2,
R coronary angiography on a 3.0-T scanner
isplayed an accuracy of 84% (27). Increasing clin-
cal data become available for CT coronary angiog-
aphy. In 1,226 patients who underwent clinically
riven coronary CT angiography to rule out coro-
ary artery stenoses and who were followed for 18
onths, Hadamitzky et al. (28) showed that there
ere only 4 events (1 unstable angina, and 3
evascularizations) in 802 individuals without ob-
tructive coronary disease in CT, as compared with
7 events (1 nonfatal infarction, 4 unstable angina
ith a total of 15 revascularization procedures) in
atients with at least 1 stenosis seen in CT angiog-
aphy (Fig. 6). Chow et al. (29) demonstrated that,
n 2,006 prospectively enrolled patients with sus-
ected CAD but a normal CT scan, the annual
vent rate was only 0.26% (as compared with 10.5%
or patients with stenoses in 3 or more coronary
rteries). In 368 patients with acute chest pain, the
OMICAT (Rule Out Myocardial Infarction us-
ng Computer Assisted Tomography) trial con-
rmed a high sensitivity of coronary CT angiogra-
hy to identify patients with acute coronary
yndromes among those who present with normal
roponin and absence of ischemic ECG changes
30). The presence of atherosclerosis on CT an-
iography had 100% sensitivity for the identifica-
ion of patients with an acute coronary syndrome.
ollander et al. (31) demonstrated that, among 481
atients who had been admitted to the emergency
oom with chest pain and a low to intermediate
ikelihood of CAD but who were discharged on the
asis of a “negative” coronary CT angiogram (no
tenoses of 50% or more), event rates in the follow-
ng year were very low: 53 patients (11%) had a
epeat hospital stay, and 51 (11%) received further
iagnostic testing, but there was no acute coronary
yndrome, no revascularization, and only 1 death
0.2%) of unclear etiology.
Coronary CT angiography visualizes anatomy,
hereas most other noninvasive tests for CAD rely
n ischemia, and the relationship between the 2 has
een tested in numerous trials. Min et al. (32)
ublished a thorough review of the potential role of
oronary CT angiography and clearly summarized
hat the presence of coronary artery stenoses in CT
ngiography has a low positive predictive value for fhe presence of inducible ischemia (29% to 44%),
hereas the negative predictive value was high in all
ublished studies (88% to 100%). Hence, CT an-
iography is likely a good test to rule out CAD but
ot a sufficient test to base revascularization on. In
act, the effectiveness of a given test to work up
atients with suspected CAD not only depends on
est characteristics (sensitivity, specificity) but also
epends substantially on the pre-test likelihood of
isease, which in turn influences the positive pre-
ictive value. In some clinical situations, anatomic
maging (coronary CT angiography) might be more
ost-effective than imaging for ischemia. A number
f recent trials have investigated this issue and
Figure 4. Detection of Coronary Artery Disease by Perfusion Stres
Apical 4-chamber view without contrast and after administration of
(A, B). Apical lateral (inducible subendocardial) perfusion defect dur
echocardiography (C), corresponding to a similar perfusion defect o
axis view in stress single-photon emission computed tomography (
emission computed tomography image at rest (E). Coronary angiog
left circumﬂex system (F). Images were obtained from the same pa
dipyridamole. Black arrows indicate subendocardium (C). White arr
sion defects (C, D) and angiographic lesions (F). Reprinted, with pe
et al. (19).s Echocardiography
Imagify at rest
ing perfusion stress
n horizontal long-
D). Single-photon
raphy with lesions in
tient at rest and with
ows indicate perfu-
rmission, from Senioround coronary CT angiography cost-effective, es-
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1070ecially when pre-test likelihood was low or inter-
ediate. Similarly, coronary CT angiography was
ound to be cost-effective in acute chest pain pa-
ients (33–37).
A new approach to identifying the presence and
everity of CAD by CT imaging is the assessment
f myocardial hypoperfusion at rest in acute coro-
ary syndromes (38) or during pharmacologic stress
Fig. 7). Several recent publications indicated the
bility of contrast-enhanced CT imaging under
tress to visualize myocardial hypoperfusion and
ound close correlation to other tests for ischemia,
uch as SPECT (39–42); 1 study could demon-
trate an enhanced accuracy of CT for the detection
f coronary stenoses when combining CT angiog-
aphy with CT myocardial perfusion imaging. The
tudies were small, but results are compelling
nough to conduct larger clinical trials.
maging of Infarct Size and Viability
ardiac MR has long been recognized for its ability
tection of Myocardial Ischemia in a
n Patient
sion cardiac magnetic resonance (CMR) images in a patient after
graft surgery with corresponding late gadolinium enhanced (LGE)
ss perfusion CMR image (Ia) showing perfusion defect of the
al myocardial wall (arrows) in the absence of LGE (Ib). Perfusion
all (IIa, arrows) during adenosine with corresponding presence of
subendocardial low signal intensity in the left anterior descending
ry perfusion areas was not regarded as signiﬁcant perfusion deﬁ-
fact. Reprinted, with permission, from Bernhardt et al. (26).o detect scars after myocardial infarction through date gadolinium enhancement (LGE) (43). In ad-
ition to clinical work, LGE CMR is being increas-
ngly used in clinical trials to measure effects of
ovel medical therapies such as cyclosporine (44),
X06—a naturally occurring fibrin-derived peptide
45)—as well as interventional therapies such as
schemic post-conditioning during primary PCI
46). Old infarcts show transformation into lipid
issue, and an analysis of 53 patients with past
yocardial infarction showed that 89% of patients
ith an infarct age of 3 years or more had detectable
atty deposits in the LV wall in CT imaging (47). It
as recently been recognized that CMR, next to
late enhancement,” also allows imaging of myocar-
ial edema in the acute setting with T2-weighted
maging. In vivo studies using T2-weighted mea-
urement of myocardium at risk showed that the
ean time for final infarct size to reach 50% of the
rea at risk in humans is 288 min (48).
In echocardiography, strain imaging can provide
nformation on viability. Longitudinal strain imag-
ng from speckle tracking echocardiography was
sed to identify viable myocardium in 90 patients
ith chronic ischemic LV dysfunction (49). A
egional strain value of 4.5% discriminated be-
ween segments with viable myocardium and those
ith transmural scar with a sensitivity of 81.2% and
pecificity of 81.6% (49).
rognosis/Risk Stratification
arious imaging methods use different strategies to
ssess the risk of future cardiovascular events. Echo-
ardiography mainly assesses wall motion, SPECT
nd PET are targeted at myocardial perfusion, MR
maging is used to detect infarct scars, and CT
ttempts to image the culprit itself, atherosclerotic
esions in the coronary artery tree.
The prognostic value of peak and post-exercise
readmill echocardiography was evaluated in 2,947
atients (50). Although post-exercise imaging with
erivation of wall motion score was predictive of
ajor cardiac events, imaging at peak exercise was
dditive as it detected patients with ischemia that
ere not identified after exercise (50). Another
tudy from the same institution (51) evaluated the
ncremental value of echocardiographic imaging in
atients with normal stress ECG undergoing tread-
ill stress. In 4,004 patients, ischemia on stress
chocardiography more than doubled the rate of
ardiac death or myocardial infarction during the
ollowing 5 years, whereas a normal stress echocar-Figure 5. CMR for De
Post-Revascularizatio
Adenosine stress perfu
coronary artery bypass
images. Adenosine-stre
inferior and inferosept
deﬁcit of the lateral w
LGE (IIb, arrows). The
and right coronary arteiogram predicted a low yearly event rate of 0.64%
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1071n those who also had a normal resting echocardio-
ram (51).
In another study, global strain rate was a power-
ul and independent predictor (HR  2.16) of
ll-cause mortality in individuals undergoing do-
utamine stress echocardiography and provided in-
remental information over baseline clinical and
chocardiographic variables (52). Among LV geo-
etric patterns, concentric hypertrophy had the
orst outcome.
Myocardial perfusion imaging has long been
ecognized to have substantial prognostic value.
ew data illustrate that, besides predicting mortal-
ty and infarcts, myocardial perfusion SPECT
ight also predict heart failure (53). In a multi-
enter, prospective, observational study of 3,835
AD patients undergoing stress myocardial perfu-
ion SPECT, 71 (1.8%) developed new-onset heart
ailure over 3 years (54). Renal dysfunction, end-
ystolic volume index, and large stress perfusion
efect were independent predictors of heart failure,
nd the combination of the 3 had the greatest
ncremental prognostic value (Fig. 8). Whether
arly aggressive therapy can modify the risk for
eveloping HF in these patients is an important
tudy to undertake next.
To date, prognostic studies with myocardial per-
usion SPECT in elderly populations are limited.
lthough elderly persons constitute only 6.1% of
he U.S. population, they suffer two-thirds of all
ardiovascular deaths. Patients 75 years of age
n  5,200) were followed for a mean of 2.8 years
fter myocardial perfusion scintigraphy (55).
oth SPECT-measured ischemia and fixed de-
ects added incrementally to pre-SPECT data.
mong the 684-patient subgroup who had an
xtended mean follow-up period of 6.2 years, an
nteraction between early treatment and myocar-
ial ischemia by SPECT was present; increasing
schemia was associated with increasing survival
ith early revascularization, whereas in the set-
ing of little or no ischemia, medical therapy had
mproved outcomes (55). It has to be noted that
his report did not randomize patients to medical
reatment versus revascularization and the reason
or impaired survival with early revascularization
s not known.
As an alternative strategy to traditional rest-stress
PECT protocols, a recent study advocates per-
orming the stress study first (56). Rest imaging is
erformed only if the stress study is equivocal or
learly abnormal. Accordingly, all-cause mortality
as assessed in 16,854 consecutive patients who pad a normal gated stress SPECT; 8,034 (47.6%)
ere studied with stress-only protocol, and 8,820
52.4%) had both stress and rest imaging. Over a
edian follow-up period of 4.5 years, the overall
nadjusted annual mortality rate in patients who
ad a normal SPECT with a stress-only protocol
as lower than in those who required additional
est imaging (2.57% vs. 2.92%, p  0.02). No
ignificant differences in adjusted patient mortality
ere seen between the 2 imaging protocols, but the
tress-only group received a 61% lower radiophar-
aceutical dose (56), which supports the notion
hat additional rest imaging is not required in a
elected group of patients with normal initial stress
yocardial perfusion SPECT.
As compared with SPECT, PET has higher
iagnostic accuracy for detecting CAD (owing to
etter resolution, attenuation correction, and higher
nergy radiotracers) and might be a better predictor
f events. In 229 patients with suspected myocardial
schemia who underwent 13N-ammonia PET, the
ong-term prognostic value of coronary flow reserve
CFR) was assessed over a mean of 5.4 years (57).
ajor adverse cardiac events (MACE), including
9 cardiac deaths, occurred in 78 (34%) patients.
bnormal PET perfusion (n  126) was associated
ith a higher incidence of MACE (p  0.001) and
ardiac death (p  0.05). In patients with normal
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Figure 6. Prognostic Value of CT Coronary Angiography
Kaplan-Meier curve for cardiac events in 1,256 patients investiga
computed tomography (CT) angiography. Cardiac events are deﬁ
death, nonfatal myocardial infarction, unstable angina requiring
onary revascularization later than 90 days after coronary CT angi
rate for patients without obstructive coronary artery disease (CA
0.25%; for patients with obstructive CAD (brown line), it was 4.3
95% conﬁdence interval: 7.2 to 36.0). Reprinted, with permission
et al. (28).e CAD
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1072iated with a higher annual event rate over 3 years
or MACE (1.4% vs. 6.3%; p  0.05) and cardiac
eath (0.5% vs. 3.1%; p  0.05) as compared with
ormal CFR. In patients exhibiting abnormal per-
usion, CFR remained predictive throughout the
0-year follow-up (p  0.001). Hence, abnormal
FR in 13N-ammonia PET is an independent
redictor of adverse outcome (58) (Fig. 9).
Late gadolinium enhancement CMR provides
rognostic information, beyond other measures of
isk, and more data have become available (59,60).
study of 349 patients with severe ischemic car-
iomyopathy and mean LV ejection fraction of 24%
emonstrated that a greater semiquantitative mea-
ure of scar by LGE was associated with higher
ortality or need for cardiac transplantation (61).
atients with new scars as detected by LGE after
revascularization procedure were shown to have
3.1-fold greater risk of adverse outcomes com-
ared with those without new scars, whereas
roponin levels and ejection fraction had no
redictive value (62).
Imaging of coronary artery calcification has been
he mainstay of risk stratification by CT. Recently
Figure 7. Example of Single-Vessel Disease Identiﬁed by Stress
A 59-year-old obese man with no prior cardiac history who present
(CT) perfusion showed a large perfusion defect in the anteroseptal,
noncalciﬁed plaque in the proximal left anterior descending corona
(SPECT) myocardial perfusion imaging (MPI) images with fully rever
angiography in the left anterior oblique caudal view showing sever
Reprinted, with permission, from Blankstein et al. (39).ublished data in large patient cohorts support the itrong prognostic power of coronary calcium mea-
urements in asymptomatic individuals (63–65).
in et al. (66) addressed an interesting question in
study that included 422 individuals (mean age 47
ears) who had a calcium score of 0 (absence of
alcium): what is the “warranty period” of a 0
alcium scan? The group was followed for a period
f 5 years by annual CT scans for coronary calcium.
he authors documented conversion from 0 cal-
ium scores to detectable calcium in 2, 5, 24, 26,
nd 49 individuals in follow-up years 1, 2, 3, 4, and
, with a mean time to conversion of 4.1 years. Age,
iabetes, and smoking were independent predictors
f conversion. The authors conclude that there is a
ery low rate of conversion to positive calcium score
p to 4 years (indeed, much of the early conversions
an probably be explained by the less-than-perfect
eproducibility of coronary calcium scans) and that
uring this time period repeat calcium scanning is
ot warranted. Whether coronary CT angiography,
y documenting noncalcified plaque, might have
dditional prognostic value beyond coronary cal-
ium has been much debated. The question was
ddressed in a cohort of 423 mostly symptomatic
PI
ith chest pain and dyspnea on exertion. Computed tomography
rior, and anterolateral walls (A). (B) CT angiography showed large
rtery (LAD); (C) single-photon emission computed tomography
defect throughout the mid and apical anterior wall. (D) Invasive
nosis in LAD before the takeoff of the ﬁrst diagonal branch.CT M
ed w
ante
ry a
sible
e stendividuals who underwent clinically indicated cor-
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 3 , N O . 1 0 , 2 0 1 0
O C T O B E R 2 0 1 0 : 1 0 6 5 – 7 7
Achenbach et al.
Year in CAD
1073Figure 8. Global Chi-Square Values for Predicting New-Onset Refractory HF in a Study of 3,835 Patients With
Coronary Artery Disease
Global chi-square values for predicting new-onset refractory heart failure signiﬁcantly and incrementally increase when chronic renal dys-
function (CRD), end-systolic volume index (ESVI), and summed stress score (SSS) in myocardial perfusion single-photon emission com-
puted tomography (SPECT), all of which were determined by multivariable Cox analysis, are combined. Reprinted, with permission, from
Nakata et al. (54).Su
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Figure 9. Predictive Value of CFR Measured by 13N-ammonia PET
Coronary ﬂow reserve (CFR) is an independent predictor of adverse outcome. It provides a 3-year “warranty” period of event-free survival
for patients with normal CFR and normal positron emission tomography (PET) perfusion (3-year follow-up). Abnormal CFR predicts
adverse outcome, that is, major adverse cardiac event (MACE) (A) and cardiac death (B), despite normal perfusion. This is reﬂected by
the higher annual event rate (%/year) in abnormal CFR (C). Reprinted, with permission, from Dilsizian et al. (58).
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1074nary CT angiography and were then followed for
median period of 670 days (67). Twenty-one
atients experienced an event (6 deaths, myocardial
nfarction in 8 patients, and unstable angina requir-
ng revascularization in 7 patients). After adjust-
ent for calcium scores (threshold: calcium score
,000), the presence of any stenosis 50%, the
umber of diseased coronary artery segments, the
umber of segments with obstructive plaque, and
he presence of noncalcified plaque were indepen-
ent predictors of events. Thus, the authors
onclude that CT angiography has prognostic
alue independent of the calcium score. Although
he reported calcium cutoff (score of 1,000) seems
igh, the authors reported in a personal commu-
ication that using lower calcium score thresh-
lds yielded the same results. Another study that
ighlighted the potential of CT to detect and
nalyze noncalcified plaque was published by
etani et al. (68), in a different context. They
maged 189 patients scheduled for elective revas-
ularization by contrast-enhanced 64-slice CT
nd measured the volume of plaque in the culprit
esion. They could show that the total volume of
therosclerotic plaque in the target lesion mea-
ured by CT as well as the volume of plaque with
ow CT attenuation (below 50 Hounsfield units
nd below 150 Hounsfield units, respectively)
orrelated with the occurrence of peri-procedural
yocardial infarction as detected by a troponin
ncrease.
A new measure of cardiovascular risk might be
he amount of pericardial fat, which can easily be
easured from nonenhanced CT scans. Cheng et
l. (69) used automated measurements of pericar-vasc Imaging 2009;2:451–9. son to 13N-ammotroke, and late revascularization in a cohort of
,751 asymptomatic individuals. They found a
igher mean pericardial fat volume in 58 patients
ith events as compared with patients without
vents (102  49 cm2 vs. 85  38 cm2, p  0.007),
ven after adjusting for risk factors and the presence
f coronary calcium.
ew Guidelines and Recommendations
ecognizing the importance of high procedural
uality in imaging, several societies published
uidelines on data acquisition and interpretation in
ardiac imaging. The American Society of Nuclear
ardiology published “Imaging Guidelines for Nu-
lear Cardiology Procedures: PET myocardial per-
usion and metabolism clinical imaging” (58), and
he Society of Cardiovascular Computed Tomog-
aphy published recommendations for data acquisi-
ion and reporting of coronary CT angiography in 2
eparate documents (70,71). Similarly, the Society
or Cardiovascular Magnetic Resonance published
ew guidelines for reporting CMR examinations in
comprehensive manner (72). Regarding clinical
ndications for cardiac CT and CMR, 2 very recent
xpert Consensus Documents have become avail-
ble (73,74). “Appropriate Use Criteria” for cardiac
adionuclide imaging have been published (75) and
n update of the “Appropriateness Criteria” for
ardiac CT is expected very soon.
eprint requests and correspondence: Dr. Stephan Achen-
ach, Department of Internal Medicine II (Cardiology),
niversity of Erlangen, Ulmenweg 18, Erlangen 91054,dial fat burden to predict cardiac death, infarction, Germany. E-mail: stephan.achenbach@uk-erlangen.de.E F E R E N C E S
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